Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Béatrice Desvergne, Walter Wahli · Endocrine Reviews · 1999
I. Introduction II. Molecular Aspects A. PPAR isotypes: identity, genomic organization and chromosomal localization B. DNA binding properties C. PPAR ligand-binding properties D. Alternative pathways for PPAR activation E. PPAR-mediated transactivation properties III. Physiological Aspects A. Differential expression of PPAR mRNAs B. PPAR target genes and functions in fatty acid metabolism C. PPARs and control of inflammatory responses D. PPARs and atherosclerosis E. PPARs and the development of the fetal epidermal permeability barrier F. PPARs, carcinogenesis, and control of the cell cycle IV. Conclusions
Cited by 3,086 works. doi:10.1210/edrv.20.5.0380
Authors
References
- Positional cloning of the mouse obese gene and its human homologue
- The pathogenesis of atherosclerosis: a perspective for the 1990s
- Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- Leptin and the regulation of body weight in mammals
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
- The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases